This site is intended for U.S. healthcare professionals.

Visit Pfizer Medical

Menu

Close

Sign InLog Out ProductsOrderMaterialsCo-pay Cards & Patient Savings OffersRequest SamplesHospital ProductsVaccinesPatient AssistancePfizer Oncology TogetherPfizer RxPathwaysExplore ContentEventsMaterialsVideosContact

Menu

Close

EventsMaterialsVideos
Meningococcal Disease

Meningococcal meningitis is an uncommon bacterial infection that attacks the brain and spinal cord membranes. Bacteria called Neisseria meningitidis cause meningococcal disease and there are 5 leading types: serogroups A, B, C, W, and Y. Vaccination can help protect against all 5 of these serogroups.
 
Neisseria meningitidis is transmitted via respiratory secretions, which is more likely to occur due to close or prolonged contact, such as kissing or living in the same household. Nasopharyngeal carriage rates of N. meningitidis are highest in adolescents and young adults. 

Meningococcal disease caused by the 5 leading serogroups (A, B, C, W, and Y) can progress from flu-like symptoms to death in as little as 24 to 48 hours. Despite prompt treatment, 10% of cases are fatal and 20% of cases can result in permanent sequelae.

Events

Browse and register for speaker programs

Events

Browse and register for speaker programs

Materials

View materials for you and your patients

Videos

Find videos and on-demand webinars

To report an adverse event, please call 1-800-438-1985

Pfizer for Professionals 1-800-505-4426

This site is intended only for U.S. healthcare professionals. The products discussed in this site may have different product labeling in different countries. The information provided is for educational purposes only.

© 2024 Pfizer Inc. All rights reserved.

PP-PBI-USA-0157
You are now leaving Pfizer  You are now leaving a Pfizer operated website. Links to all outside sites are provided as a resource to our visitors. Pfizer accepts no responsibility for the content of sites that are not owned and operated by Pfizer.

PP-MCL-USA-0367